Endocrinology News

A novel oral GLP-1 receptor agonist was well-tolerated and linked with weight loss compared with placebo in healthy adults with overweight or obesity, according to top-line results of a phase 1 study.

The FDA has granted 510(k) clearance for an insulin patch pump for adults with type 1 or type 2 diabetes, Embecta Corp. announced.

One important investment vehicle to understand when working toward slow and steady growth is the index fund.

High consumption of ultraprocessed food, especially processed meats and sugar-sweetened beverages, was associated with elevated risk for heart disease and stroke, researchers reported.

Bariatric surgery for weight loss was associated with improvements in blood pressure and antihypertensive use among patients with obesity compared with medical therapy and/or lifestyle management, a speaker reported.

With new guidance now available on monitoring people with early-stage type 1 diabetes, it is crucial for providers to encourage people at high risk to get tested, according to a presenter.

Pregnant women with diabetes can use automated insulin delivery systems with settings optimized to achieve tight glycemic targets, according to two speakers at the Association of Diabetes Care and Education Specialists annual meeting.

The Healio news team won an APEX Grand Award for its Treating Obesity resource center, a collection of the latest news and perspectives on medications for obesity.

Canagliflozin may reduce albuminuria and patient-specific eGFR decline in patients with type 2 diabetes and microalbuminuria, researchers found in a parallel, open-labeled trial.

The COVID-19 pandemic had a great impact on the health care system and the well-being of health care professionals, the effects of which are still felt today.